Results 251 to 260 of about 118,302 (314)

Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a BTLA Agonist Antibody (Venanprubart) in Healthy Participants, Patients with Systemic Lupus Erythematosus, and Patients with Psoriasis: Results From Three Phase 1 Studies

open access: yesClinical Pharmacology in Drug Development, Volume 15, Issue 1, January 2026.
Abstract Venanprubart (LY3361237), an agonist antibody to B and T lymphocyte attenuator (BTLA), was developed as a potential treatment for autoimmune disorders, including systemic lupus erythematosus (SLE) and psoriasis. We tested venanprubart in three human Phase 1 safety studies: a single ascending dose (SAD) study in healthy participants (1/2/5/15 ...
Andrew C. Vendel   +9 more
wiley   +1 more source

Necrotizing Pseudomonal Sinusitis in a Transplant Patient. [PDF]

open access: yesCureus
Gomez CN   +4 more
europepmc   +1 more source

A Rational Approach to Pharmacotherapy in Pregnancy

open access: yesThe Journal of Clinical Pharmacology, Volume 66, Issue 1, January 2026.
Abstract Most pregnant individuals are exposed to at least one medication, whether prescription or over the counter, during pregnancy. Despite the ubiquity of medication use in pregnancy, there remains no standardized framework to guide clinicians in selecting the most appropriate pharmacotherapy that balances maternal needs with fetal safety. This gap
Gregory W. Kirschen   +2 more
wiley   +1 more source

Invasive fungal sinusitis by <i>Scedosporium boydii</i> in an immunocompromised patient. A case report. [PDF]

open access: yesMed Mycol Case Rep
Rey-Suarez C   +5 more
europepmc   +1 more source

Clinical Characteristics of Patients Initially Suspected of Long COVID: A Case Series From a Specialized Outpatient Clinic

open access: yesJournal of General and Family Medicine, Volume 27, Issue 1, January 2026.
ABSTRACT Background Sequelae of the acute phase of coronavirus disease 2019 (COVID‐19), termed long COVID, are characterized by a variety of symptoms, including neurological manifestations. Diagnosing long COVID requires excluding alternative conditions that could explain the symptoms.
Masayuki Ohira   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy